Skip to content

Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy

Randomized Single Center Clinical Trial Comparing Loop Ileostomy Versus Loop Transverse Colostomy in Patients After Major Anterior Resections

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05745909
Acronym
LIVELOC
Enrollment
150
Registered
2023-02-27
Start date
2023-03-01
Completion date
2024-07-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms, Ostomy, Rectal Neoplasms

Keywords

Rectal cancer, Low anterior resection, Loop transverse colostomy, Loop ileostomy, Stoma site infections

Brief summary

The purpose of this study is to determine which stoma creation technique is preferable after low anterior resection of the rectum.

Detailed description

The investigators enroll patients with a histologically confirmed diagnosis of primary rectal cancer with or without prior chemoradiotherapy who were hospitalized at the Ufa Republican Clinical Oncology Center from February 2023 to February 2024. All patients undergo planned laparoscopic or open low-anterior resection of the rectum with total mesorectal excision. Patients are randomized into 2 groups in a 1:1 ratio. In the first group, a loop transverse colostomy is created, and in the second group, a loop ileostomy is created. The stoma exit sites are marked in advance the day before the surgery. The bowels are prepared by mechanical means (a polyethylene glycol-based laxative with a cleansing enema) according to a standard procedure before the surgery. Standardized stoma creation techniques are used. The resected parts are collected through a separate access. Patients are followed up for 60 days after surgery. The sample size should be 124 patients to reach statistical significance (α = 0.05, study power 80%, confidence interval (CI) = 95%.). Considering possible losses during the study, the number of patients was increased to 130. The investigators hypothesis is that the loop ileostomy group has a 20% higher incidence of stoma dysfunction but a 20% lower incidence of SSI (stoma site infections) compared to the loop colostomy group.

Interventions

PROCEDURELaparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy

The loop transverse colostomy is matured without torsion using a plastic retainer. The stoma protrudes 2-3 cm. The loop of the transverse colon is sutured with interrupted sutures using an absorbable 3/0 polyglactin suture without piercing the intestinal wall. The intestinal lumen is opened through a transverse incision on the antimesenteric border.

PROCEDURELaparoscopic or open low-anterior resection of the rectum with TME and created loop ileostomy

The loop ileostomy is matured 25-30 cm from the ileocecal angle without torsion and without a retainer, so that stoma protrudes 2-3 cm. The loop of the ileum is sutured with interrupted sutures using an absorbable 3/0 polyglactin suture without piercing the intestinal wall. The intestinal lumen is opened through a transverse incision on the antimesenteric border.

Sponsors

Republican Clinical Oncological Dispensary, Ministry of Health of the Republic of Bashkortostan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Histologically confirmed adenocarcinoma of the rectum (stages 1-3 according to MRI) * ECOG status 0-2, * ASA≤3. * At least 18 years of age * Written informed consent

Exclusion criteria

* Emergency surgery; * Previously formed stoma; * Stage 4 disease; * Obstructive resection of the rectum; * Patients older than 79 years

Design outcomes

Primary

MeasureTime frameDescription
SSI60 days after surgeryincidence of stoma site infections
Ileus60 days after surgeryincidence of stoma dysfunction

Secondary

MeasureTime frameDescription
Length of hospital stayFrom date of surgery until the date of discharge, assessed up to 60 daysthe number of days from surgery to discharge
Time to stoma closurewithin the first 6 months days after surgerythe number of days from surgery to stoma closure
Quality of life in patients with ostomywithin the first 60 days after surgeryestimated using EORTC QLQ-CR29
Time to adjuvant postoperative chemotherapywithin the first 2 months days after surgerythe number of days from surgery to hospitalization for first chemotherapy
Time to first stool60 days after surgerythe occurrence of anything other than serous-hemorrhagic contents in the colostomy bag
Readmission ratewithin the first 60 days after surgeryreadmission rate

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026